Skip to main content

Table 1 Baseline information on patients

From: Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious

 

Etanercept plus methotrexate

Etanercept only

P value

n

57

40

 

Age (years)

51.1 ± 1.7

53.3 ± 2.0

Not significant

Female (%)

91

70

< 0.02

Disease (years)

14.5 ± 1.3

12.7 ± 1.5

Not significant

Rheumatoid factor-positive (%)

95

90

Not significant

Shared epitope-positive (%)

78

87

Not significant

  1. Values presented as mean ± standard error of the mean. Comparisons are by unpaired Student t test for continuous variables and by Fisher exact test for dichotomous variables.